Search the Newsreel

Admiral Group plc Just Missed Revenue By 10%: Here's What Analysts Think Will Happen Next

Archer-Daniels-Midland Co (ADM) Aktuelle Aktien-News

Is ADMA Biologics (ADMA) Cheap On Lawsuit Risks Or Is Its Rebound Priced In?

Zacks Research Upgrades Archer Daniels Midland (NYSE:ADM) to "Strong-Buy"

Zacks Research has upgraded Archer Daniels Midland (NYSE:ADM) from a "hold" to a "strong-buy" rating. This upgrade comes despite the broader analyst consensus remaining "Hold" with an average price target of $79.67. The company recently reported strong quarterly results, beating EPS expectations and showing …

Noticias de acciones de Archer-Daniels-Midland Co (ADM)

Admiral Group (LSE:ADM) Stock Gets Fair Value Bump As Analysts Rework Targets

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Admiral Group is back in focus after analysts lifted fair value estimates from £34.35 to £36.08 and several banks moved price targets into a …

Assenagon Asset Management S.A. Buys 829,641 Shares of Archer Daniels Midland Company $ADM

Assenagon Asset Management S.A. significantly increased its stake in Archer Daniels Midland Company (NYSE:ADM) by 725.0% in the second quarter, purchasing an additional 829,641 shares to own a total of 944,082 shares valued at $72,128,000. Other institutional investors also adjusted their positions in ADM. …

ARCHER DANIELS MIDLAND AKTIE: AI-Analysen, Prognose & Kursziel

Archer-Daniels-Midland Company 2026 Q2 - Results - Earnings Call Presentation (NYSE:ADM) 2026-08-07

Archer-Daniels-Midland Company (ADM) has published its Q2 2026 earnings call presentation. The company reported EPS of $1.84, beating estimates by $0.40, and revenue of $22.68 billion, which missed estimates by $379.59 million. This presentation provides details discussed during their recent earnings call.

ADMA Biologics 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

Kahn Swick & Foti, LLC (KSF) is reminding investors of ADMA Biologics, Inc. (ADMA) with losses over $100,000 that the deadline to file lead plaintiff applications in a securities class action lawsuit is August 10, 2026. The lawsuit alleges that ADMA and its executives …

ADMA BIOLOGICS CLASS ACTION DEADLINE AUGUST 10th: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against ADMA Biologics, Inc. on behalf of investors who purchased securities between August 9, 2024, and March 25, 2026. The lawsuit alleges that ADMA made false statements and failed to disclose that it …

Discipline and Rules-Based Execution in ADM Response

This article analyzes Archer-Daniels-Midland Company (NYSE: ADM) using AI models to suggest trading strategies. It highlights a weak near and mid-term sentiment but a strong long-term outlook, identifying a 30.0:1 risk-reward setup targeting an 8.5% gain. Three distinct strategies—Position Trading, Momentum Breakout, and Risk …

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Kahn Swick & Foti, LLC (KSF) has announced a class action securities lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) for alleged federal securities law violations between August 9, 2024, and March 25, 2026. Investors are accused of suffering losses due to undisclosed related-party transactions, …

Archer Daniels Midland Co. stock underperforms Friday when compared to competitors

Archer Daniels Midland Co. (ADM) stock fell by 1.19% on Friday, closing at $76.59, despite an overall positive trading session for the broader market. The S&P 500 Index rose 0.62% and the Dow Jones Industrial Average increased by 0.28%. This marked the third consecutive …

ADMA Shareholder Alert: August 10, 2026 Lead Plaintiff Deadline in ADMA Biologics, Inc. Securities Class Action - Contact The Gross Law Firm

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA). Shareholders who purchased shares of ADMA during the class period listed are encouraged to contact the firm regarding possible lead …

Is Archer Daniels Midland (ADM) Stock Undervalued Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in …

Who's Buying or Selling Archer-Daniels-Midland Co (CHIX:1ADMm) Stock Today?

This article provides a detailed stock summary for Archer-Daniels-Midland Co (CHIX:1ADMm) from GuruFocus, including key financial ratios, market capitalization, and valuation metrics. It highlights GuruFocus's detection of three severe warning signs for the stock and mentions the absence of guru or insider trade data. …

Admiral Group plc 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:AMIGY) 2026-08-07

180 Wealth Advisors LLC Buys New Stake in Archer Daniels Midland Company $ADM

180 Wealth Advisors LLC has acquired a new stake of 16,411 shares, valued at approximately $1.25 million, in Archer Daniels Midland Company (NYSE:ADM) during the second quarter. This move comes as other institutional investors have also adjusted their holdings in ADM, which recently reported …

Archer-Daniels-Midland Co Stock Historical Valuations | CHIX:1ADMm

This page provides a summary of Archer-Daniels-Midland Co (CHIX:1ADMm) stock, including its current valuation metrics such as P/E ratio, P/B ratio, market cap, and enterprise value. It also highlights severe warning signs detected by GuruFocus for the stock and offers access to detailed financial …

Archer-Daniels-Midland Co (CHIX:1ADMm) Stock Price, Trades & News

This article provides a detailed financial overview of Archer-Daniels-Midland Co (CHIX:1ADMm), including its stock price, market capitalization, P/E ratio, and various financial strength, growth, momentum, liquidity, dividend, and profitability metrics. It also lists upcoming earnings dates, recent press releases, and answers frequently asked questions …

ADMA INVESTOR ALERT: ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Hagens Berman has filed a securities fraud class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) alleging misrepresentations regarding the company's financial condition, revenue recognition, inventory distribution, and business practices. The lawsuit claims that the company engaged in an undisclosed related-party transaction and used …

Admiral Group PLC (AMIGF) (H1 2026) Earnings Call Highlights: Strong Underwriting Discipline ...

This article first appeared on GuruFocus. Group Profit Before Tax: GBP429 million, down 18% versus H1 2025 but broadly in line with H2 2025. Group Combined Ratio: 78.5%, modestly higher than last year's exceptional 77.7%. Group Loss Ratio: Stable at 57%. Expense Ratio: 21%. …

ADMA Q2 Earnings Meet, Revenues Miss on Bivigam Weakness

ADMA Biologics (ADMA) reported Q2 2026 earnings that matched analyst estimates at 16 cents per share, but revenues of $124.4 million missed expectations due to a significant decline in Bivigam sales. The company's Asceniv product, however, showed strong growth, helping to drive an expansion …

Is ADM’s Stronger Outlook, Dividend Hike and New Debt Altering The Investment Case For Archer-Daniels-Midland (ADM)?

Archer-Daniels-Midland (ADM) recently reported stronger quarterly sales and net income, alongside a higher full-year earnings outlook, driven by improved biofuels margins. The company also declared a dividend hike and issued new debt. While these developments are positive, particularly for biofuels, the core investment case …

Archer Daniels Midland (ADM) Stock May Be 36% Undervalued After Raised Outlook

Archer-Daniels-Midland (ADM) stock appears to be 36% undervalued according to a Discounted Cash Flow (DCF) model, suggesting an intrinsic value of about $121 per share against its current price of $77.58. This valuation comes despite the company's recent raised earnings outlook and stronger biofuel …

Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 10, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ADMA …

ADM’s PRIOME® Metabolic Health Postbiotic Wins “Dog Preventative Product of the Year” In 2026 Pet Innovation Awards

Pet Innovation Awards Annual Awards Program Recognizes Companies, Services And Products Within The Rapidly Expanding Pet Industry That Exemplify Excellence & Innovation LOS ANGELES, Aug. 06, 2026 (GLOBE NEWSWIRE) -- The 2026 Pet Innovation Awards today announced that PRIOME® Metabolic Health (MH) Postbiotic from …

ADMA Biologics (Nasdaq: ADMA) grows Q2 profit and ASCENIV sales

ADMA Biologics reported significantly higher profitability in Q2 2026, driven by strong ASCENIV sales, despite modest overall revenue growth. The company announced a 24% increase in ASCENIV revenue, contributing to a 69% gross margin and an 11% rise in GAAP net income. ADMA reiterated …

Archer Daniels Midland Company (NYSE:ADM) Plans Quarterly Dividend of $0.52

Archer Daniels Midland Company (NYSE:ADM) announced a quarterly dividend of $0.52 per share, payable on September 9th to shareholders of record on August 19th. This equates to an annualized dividend of $2.08, representing a 2.7% yield, and marks the company's 53rd consecutive year of …

Archer-Daniels-Midland Co (CHIX:1ADMm) Stock Earnings Transcripts

This page provides a comprehensive list of Archer-Daniels-Midland Co (CHIX:1ADMm) earnings call transcripts and conference transcripts dating back to 2018. It includes details such as the date of the call/conference and the stock price at that time. The list covers quarterly earnings calls, investor …

ADMA Biologics (ADMA) Is Up 6.3% After Faster Net Income Growth Than Sales In Q2 2026

Admiral reports resilient first-half performance as growth and shareholder returns remain in focus

Archer-Daniels-Midland Co (ADM) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

ADMA Biologics Inc (ADMA) (Q2 2026) Earnings Call Highlights: Ascentiv Surges 24% as Gross ...

Earnings call transcript: ADMA Biologics posts strong margins in Q2 2026

This article first appeared on GuruFocus. Total Revenue: $124.4 million in Q2 2026, a 2% increase year-over-year. Ascentiv Revenue: $102.9 million, up 24% year-over-year. Bivigam Revenue: $19.4 million, reflecting sequential improvement from Q1. Gross Margin: 69%, up from 55% in the prior-year period. Adjusted …